Literature DB >> 22738822

Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis.

Christian Borg Xuereb1, Rachel L Shaw, Deirdre A Lane.   

Abstract

OBJECTIVE: Atrial fibrillation (AF) patients are prescribed oral-anticoagulant (OAC) therapy, often warfarin, to reduce stroke risk. We explored existing qualitative evidence about patients' and health professionals' experiences of OAC therapy.
METHODS: Systematic searches of eight bibliographic databases were conducted. Quality was appraised using the Critical Appraisal Skills Programme tool and data from ten studies were synthesised qualitatively.
RESULTS: Four third-order constructs, emerged from the final step in the analysis process: (1) diagnosing AF and the communication of information, (2) deciding on OAC therapy, (3) challenges revolving around patient issues, and (4) healthcare challenges. Synthesis uncovered perspectives that could not be achieved through individual studies.
CONCLUSION: Physicians' and patients' experiences present a dichotomy of opinion on decision-making, which requires further exploration and changes in practice. Outcomes of workload pressure on both health professionals and patients should be investigated. The need for on-going support and education to patients and physicians is critical to achieve best practice and treatment adherence. PRACTICE IMPLICATIONS: Such research could encourage health professionals to understand and attend better to the needs and concerns of the patient. Additionally these findings can be used to inform researchers and healthcare providers in developing educational interventions with both patients and health professionals.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22738822     DOI: 10.1016/j.pec.2012.05.011

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  15 in total

1.  Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

Authors:  David R Van Wagoner; Jonathan P Piccini; Christine M Albert; Mark E Anderson; Emelia J Benjamin; Bianca Brundel; Robert M Califf; Hugh Calkins; Peng-Sheng Chen; Nipavan Chiamvimonvat; Dawood Darbar; Lee L Eckhardt; Patrick T Ellinor; Derek V Exner; Richard I Fogel; Anne M Gillis; Jeff Healey; Stefan H Hohnloser; Hooman Kamel; David A Lathrop; Gregory Y H Lip; Reena Mehra; Sanjiv M Narayan; Jeffrey Olgin; Douglas Packer; Nicholas S Peters; Dan M Roden; Heather M Ross; Robert Sheldon; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2014-11-18       Impact factor: 6.343

2.  Comparing Patient and Provider Experiences with Atrial Fibrillation to Highlight Gaps and Opportunities for Improving Care.

Authors:  Bonnie M Vest; Brian M Quigley; Denise F Lillvis; Caroline Horrigan-Maurer; Rebecca S Firth; Anne B Curtis; Jeffrey M Lackner
Journal:  J Gen Intern Med       Date:  2022-01-06       Impact factor: 6.473

3.  Preferences for anticoagulation therapy in atrial fibrillation: the patients' view.

Authors:  Björn Böttger; Inga-Marion Thate-Waschke; Rupert Bauersachs; Thomas Kohlmann; Thomas Wilke
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

4.  Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for predicting 30-day adverse events in emergency department patients with atrial fibrillation.

Authors:  Tyler W Barrett; Cathy A Jenkins; Wesley H Self
Journal:  Ann Emerg Med       Date:  2014-09-20       Impact factor: 5.721

5.  Patients' knowledge on oral anticoagulant treatment in Hungary.

Authors:  Reka Viola; Helga Fekete; Ildiko Csoka
Journal:  Int J Clin Pharm       Date:  2017-10-19

6.  Patient Perspectives on Factors Affecting Direct Oral Anticoagulant Use for Stroke Prevention in Atrial Fibrillation.

Authors:  Kristina Medlinskiene; Susan Richardson; Beth Fylan; Katherine Stirling; Marcus Rattray; Duncan Petty
Journal:  Patient Prefer Adherence       Date:  2021-05-10       Impact factor: 2.711

7.  Patient values and preferences when choosing anticoagulants.

Authors:  Ana M Palacio; Irene Kirolos; Leonardo Tamariz
Journal:  Patient Prefer Adherence       Date:  2015-01-22       Impact factor: 2.711

Review 8.  Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review.

Authors:  Gemma Mas Dalmau; Elisenda Sant Arderiu; María Belén Enfedaque Montes; Ivan Solà; Sandra Pequeño Saco; Pablo Alonso Coello
Journal:  BMC Fam Pract       Date:  2017-01-13       Impact factor: 2.497

9.  Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014.

Authors:  Vageesh Jain; Iain J Marshall; Siobhan L Crichton; Christopher McKevitt; Anthony G Rudd; Charles D A Wolfe
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

10.  Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study.

Authors:  David Zweiker; Robert Zweiker; Elisabeth Winkler; Konstantina Roesch; Martin Schumacher; Vinzenz Stepan; Peter Krippl; Norbert Bauer; Martin Heine; Gerhard Reicht; Gudrun Zweiker; Martin Sprenger; Norbert Watzinger
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.